Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: J Cardiovasc Pharmacol Ther. 2011 Jan 31;17(1):93–101. doi: 10.1177/1074248410389815

Table 1.

Changes in heart rate, maximal rates of contractility (dP/dt max) and relaxation (dP/dt min), O2 consumption, % O2 extraction, and cardiac efficiency at baseline and 60 min reperfusion.

Baseline Reperfusion 60 min
Heart Rate (beats/min)
 Control 276±9 269±6
 CP 269±6 262±7
 CP+MCG 269±15 279±8
dP/dt max (mmHg/s)
 Control 2024±175 735±142
 CP 1909±193 1221±141#
 CP+MCG 2012±168 1040±67#
dP/dt min (mmHg/s)
 Control −1502±124 −516±101
 CP −1542±206 −904±112#
 CP+MCG −1577±171 −716±54#
O2 consumption (μl O2/g/min)
 Control 105.1±7.8 57.6±6.8
 CP 102.2±7.0 81.4±6.8#
 CP+MCG 121.8±8.7 87.3±5.6#
% O2 extraction
 Control 72±4 76±5
 CP 76±2 85±2#
 CP+MCG 73±3 81±4
Cardiac efficiency (mmHg • beat • 0.1 μL O2 / g)
 Control 23±3 14±2
 CP 23±1 16±1
 CP+MCG 18±1 14±2

Values are mean ± SEM

Abbreviations: CP, high K+ cardioplegia; CP+MCG, high K+ cardioplegia with MnTBAP, catalase, and glutathione.

#

P < 0.05 each treatment vs. the control group

P < 0.05, CP+MCG vs. CP